Genomic interrogation of mechanism(s) underlying cellular responses to toxicants

Rupesh P Amin1, Hisham K Hamadeh, Pierre R Bushel

  • 1National Institute of Environmental Health Sciences, National Institutes of Health, P.O. Box 12233, Mail Drop F1-05, Research Triangle Park, NC 27709, USA.

Toxicology
|December 31, 2002
PubMed

Insights

Toxicogenomics uses genome-wide gene expression profiling to understand how xenobiotics affect human health. This approach reveals toxicant mechanisms, aiding in predicting chemical toxicity.

Area of Science:

  • Toxicology
  • Genomics
  • Computational Biology

Background:

  • Assessing xenobiotic impact on human health is complex.
  • Understanding mechanisms of toxicity and disease progression is crucial for compound evaluation.
  • Toxicogenomics merges genomics and toxicology to study genome-wide xenobiotic effects.

Purpose of the Study:

  • To discuss computational approaches for analyzing microarray data in toxicogenomics.
  • To elucidate mechanisms underlying cellular responses to toxicants.
  • To demonstrate the application of transcript profiling in understanding xenobiotic action.

Main Methods:

  • Utilizing cDNA microarrays for global gene expression profiling.
  • Analyzing microarray data with computational approaches.
  • Comparing gene expression patterns from different classes of xenobiotics (barbiturate and peroxisome proliferator).

Main Results:

  • Chemical-specific gene expression patterns were identified using cDNA microarrays.
  • Transcript profiling effectively discriminated between different classes of toxicants.
  • Genome-wide insights into toxicity and disease progression mechanisms were obtained.

Conclusions:

  • Transcript profiling is a valuable tool in toxicogenomics for elucidating xenobiotic mechanisms.
  • Computational analysis of microarray data provides genome-wide insight into toxicant responses.
  • This research paves the way for novel approaches to predict human xenobiotic toxicity.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...